Xtl Biopharmaceuticals XTLB Balance Sheet (2009-2025)

NASDAQ XTLB
$2.21 -0.02 (-0.91%)
As of: Sep 29, 2026 · 3:40 PM EDT
Reported Financials

Xtl Biopharmaceuticals Quarterly Balance Sheet

Periods 66 quarters
Latest Dec 2025

Xtl Biopharmaceuticals reported total assets of $0.17M and total liabilities of $0.42M for the quarter ended Dec 2025, down 93.1% year over year. This balance sheet covers 66 quarters of results from Mar 2009 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Jun2025 Dec2025
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
3.75M3.63M3.39M2.92M3.01M2.97M2.79M2.35M2.23M2.09M1.90M1.59M1.46M1.40M1.07M0.59M0.82M0.37M0.15M0.08M
Cash Due from Bank
Short-term InvestmentsInvestments (Current)
2.41M3.38M3.16M2.81M2.16M1.63M0.97M0.79M0.75M0.60M1.27M0.99M0.90M0.77M0.11M
Cash & Current Investments
3.75M6.04M3.39M6.30M3.01M6.13M2.79M5.16M4.39M3.72M2.88M2.38M2.21M2.01M2.34M1.59M1.72M1.14M0.26M0.08M
Receivables
0.14M0.10M0.10M
Securities
Inventory
Prepaid Assets
2.08M0.08M3.54M0.27M3.46M0.11M3.45M0.22M0.13M0.09M0.07M0.12M0.08M0.04M0.06M0.13M0.13M0.10M0.18M0.02M
Current Assets
5.83M6.12M6.93M6.57M6.47M6.24M6.24M5.38M3.81M2.05M1.34M0.17M
Non-Current Assets
Property, Plant & Equipment (Net)
0.00M0.00M0.00M0.00M0.22M0.19M0.17M0.19M
Long-Term Investments
-0.01M
Goodwill
3.19M
Intangibles
0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M3.82M
Goodwill & Intangibles
0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M7.08M7.01M
Other Non-Current Assets
1.87M
Non-Current Assets
0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M7.21M
Assets
6.21M6.50M7.31M6.95M6.86M6.62M6.62M5.76M4.90M4.19M3.32M2.88M2.66M2.43M2.93M2.40M9.28M8.55M0.71M0.17M
Liabilities
Current Liabilities
Accounts Payables
0.25M0.26M0.23M0.17M0.15M0.19M0.24M0.16M0.16M0.21M0.22M0.17M0.55M0.79M0.64M0.15M
Notes Payables
0.14M0.14M
Payables
0.25M0.26M0.23M0.17M0.15M0.19M0.24M0.16M0.16M0.21M0.22M0.17M0.55M0.93M0.64M0.29M
Other Accumulated Expenses
-0.28M-1.07M
Current Taxes
Total Current Liabilities
0.18M0.25M0.25M0.18M1.28M0.26M0.19M0.15M0.19M0.24M0.16M0.16M0.21M0.22M0.17M2.21M0.42M
Non-Current Liabilities
Non-Current Debt
Convertible Debt
Pension
Minority Interest
Liabilities from Discontinued Operations
Non-Current Deferred Tax Liability
0.33M0.22M
Other Non-Current Liabilities
2.64M3.41M1.05M0.02M1.75M0.69M0.04M0.07M
Total Non-Current Liabilities
1.36M2.64M2.69M0.26M3.59M1.28M0.52M0.19M0.77M0.91M0.72M0.35M
Total Liabilities
0.18M2.89M2.94M3.67M3.78M1.28M0.78M0.19M0.15M0.19M0.24M0.16M0.16M0.21M0.22M0.17M3.56M3.12M0.76M0.42M
Shareholder's Equity
Total Debt
0.14M0.14M
Common Equity
6.03M3.61M4.37M3.28M3.08M5.33M5.84M5.56M4.74M4.00M3.08M2.72M2.50M2.22M2.71M2.23M5.72M5.43M-0.05M-0.25M
Liabilities and Shareholders Equity
6.21M6.50M7.31M6.95M6.86M6.62M6.62M5.76M4.90M4.19M3.32M2.88M2.66M2.43M2.93M2.40M9.28M8.55M0.71M0.17M
Treasury Shares
Retained Earnings
-154.88M-155.60M-156.45M-155.13M-154.90M-155.72M-156.47M-157.38M-157.75M-157.97M-158.25M-157.76M-158.23M-158.77M-159.01M-164.49M-165.63M

Xtl Biopharmaceuticals Balance Sheet API

Pull Xtl Biopharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=XTLB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY